PCRX PEER ANALYSIS

Pacira BioSciences, Inc. — metric-by-metric comparison with peers and the industry median

PCRXPacira BioSciences, Inc.

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

PCRXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PCRX	ECILC	GENIL	BHC	HLN	TLRY	Ind. Median
P/E	202.16	—	46.82	—	31.28●	—	21.37
P/B	1.59	0.80	3.47	-0.88●	1.98	0.33	1.82
EV/EBITDA	10.54	33.84	14.07	4.05●	19.15	—	12.26
P/S	1.41	5.03	1.86	0.21●	3.94	0.60	2.09

Financial Health
Metric	PCRX	ECILC	GENIL	BHC	HLN	TLRY	Ind. Median
Current Ratio	4.73●	1.73	1.33	1.32	0.92	2.79	2.22
Debt/Equity	62.9%	5.9%	41.0%	-1,010.0%●	52.3%	20.4%	46.3%
NetDebt/EBITDA	1.77	-0.10●	1.10	3.71	3.50	-0.07	1.24

Profitability
Metric	PCRX	ECILC	GENIL	BHC	HLN	TLRY	Ind. Median
Net Margin	0.7%	-3.6%	4.0%	-13.5%	12.6%●	-158.8%	4.0%
ROE	0.7%	-0.6%	8.7%●	—	6.3%	-63.6%	6.4%
ROA	0.4%	-0.5%	4.8%●	-4.7%	3.2%	-49.7%	3.4%
EBITDA Margin	16.1%	14.8%	14.3%	60.0%●	25.2%	-156.2%	18.2%

Growth + Dividend
Metric	PCRX	ECILC	GENIL	BHC	HLN	TLRY	Ind. Median
Rev. Growth	4.6%	-2.3%	16.3%●	-9.9%	-26.7%	3.8%	7.5%
NI Growth	—	—	146.6%●	—	-14.2%	—	5.0%
Div. Yield	—	2.6%●	0.0%	0.0%	2.0%	—	2.0%
Payout	—	-365.1%	0.0%	0.0%	40.0%	—	0.8%

Valuation
Metric	PCRX	AMPH	PAHC	XERS	COLL	IRWD	Ind. Median
P/E	202.16	11.52	14.33	122.48	19.80	7.06●	21.37
P/B	1.59	1.18	3.77	113.04	4.75	-3.32●	1.82
EV/EBITDA	10.54	6.81	9.21	30.27	3.07●	5.30	12.26
P/S	1.41	1.27	0.91●	4.67	1.86	2.00	2.09

Financial Health
Metric	PCRX	AMPH	PAHC	XERS	COLL	IRWD	Ind. Median
Current Ratio	4.73●	3.85	3.17	2.12	1.71	1.41	2.22
Debt/Equity	62.9%	88.7%	217.6%	286.9%	258.6%	-275.1%●	46.3%
NetDebt/EBITDA	1.77	2.05	3.15	-1.61●	0.63	1.82	1.24

Profitability
Metric	PCRX	AMPH	PAHC	XERS	COLL	IRWD	Ind. Median
Net Margin	0.7%	11.0%	6.3%	3.8%	9.4%	28.3%●	4.0%
ROE	0.7%	10.4%	30.3%●	—	27.4%	—	6.4%
ROA	0.4%	4.8%	6.9%	3.4%	4.6%	26.8%●	3.4%
EBITDA Margin	16.1%	26.6%	15.0%	14.7%	76.6%●	57.3%	18.2%

Growth + Dividend
Metric	PCRX	AMPH	PAHC	XERS	COLL	IRWD	Ind. Median
Rev. Growth	4.6%	-1.1%	26.0%	41.5%●	19.9%	13.8%	7.5%
NI Growth	—	-44.1%	199.6%●	—	70.7%	—	5.0%
Div. Yield	—	—	1.5%	—	—	—	2.0%
Payout	—	—	20.4%	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PCRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.